PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Nephrology, Transplantation and Hemodialysis, Rouen University Hospital, Rouen, France dominique.bertrand@chu-rouen.fr.\', \'Department of Nephrology, Transplantation and Hemodialysis, Rouen University Hospital, Rouen, France.\', \'Department of Virology, Rouen University Hospital, Rouen, France.\', \'Department of Immunology and Biotherapies, Rouen University Hospital, Rouen, France.\', \'Institut National de la Santé et de la Recherche Médicale U1234, University of Rouen Normandy, Rouen, France.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1681/ASN.2021040480
?:hasPublicationType
?:journal
  • Journal of the American Society of Nephrology : JASN
is ?:pmid of
?:pmid
?:pmid
  • 34112706
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 4.819
?:rankingScore_hIndex
  • 246
is ?:relation_isRelatedTo_publication of
?:title
  • Antibody and T Cell Response to SARS-CoV-2 Messenger RNA BNT162b2 Vaccine in Kidney Transplant Recipients and Hemodialysis Patients.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all